Latest Breaking News On - Hannah majeski - Page 1 : vimarsana.com

/PRNewswire/ Biotheryx, Inc., a biopharmaceutical company discovering and developing a portfolio of first-in-class protein degraders with a focus on.

United statesKyle begovichHannah majeskiPhilippe drouetPrnewswire biotheryx incAmerican society of clinical oncologyClinical oncologyAnnual meetingChief executive officerMeeting presentation detailsPrincipal scientistBreast cancerSenior scientistDevelopmental therapeuticsMolecularly targeted agentsTumor biology